InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (12 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
12
T+90 hit rate
33%
T+90 mean return
-10.9%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Martin Michael Robert, Directeur Commercial. Director active across 1 company, notably Aurinia Pharmaceuticals Inc.. Aggregated, 25 reports have been recorded. Breakdown: 1 buy · 12 sells. Total volume traded: €4m. Activity tracked since 11 May 2021. The latest transaction was disclosed on 7 November 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations25 total
107,202 sharesCommon StockSEC:0001628280-23-006529:0
30,000 shares@ US$5.163.0% of flowCommon StockSEC:0001628280-22-029215:0
Ideal exit: 4 Aug 2023 (T+270)
8,500 shares0Common StockSEC:0001628280-22-005130:0
50,000 shares@ US$30.170.062% mcap25.5% of flowCommon SharesSEC:0001628280-21-023169:0
50,000 shares@ US$30.1751.0% of flowCommon SharesSEC:0001628280-21-023169
45,000 shares@ US$3.202.4% of flowCommon StockSEC:0001628280-21-021477
45,000 shares@ US$3.200.0059% mcap2.4% of flowCommon StockSEC:0001628280-21-021477:0
28,500 shares@ US$5.300.0061% mcap2.5% of flowCommon StockSEC:0001628280-21-019048:0
28,500 shares@ US$5.302.4% of flowCommon StockSEC:0001628280-21-019048
44,000 shares@ US$5.300.0094% mcap3.9% of flowCommon StockSEC:0001628280-21-018782:0
44,000 shares@ US$5.303.8% of flowCommon StockSEC:0001628280-21-018782
25,000 shares@ US$5.300.0053% mcap2.2% of flowCommon SharesSEC:0001628280-21-018603:0
25,000 shares@ US$5.302.1% of flowCommon SharesSEC:0001628280-21-018603
7,500 shares@ US$18.102.2% of flowCommon StockSEC:0001628280-21-018219
7,500 shares@ US$18.100.0054% mcap2.2% of flowCommon StockSEC:0001628280-21-018219:0
22,500 shares@ US$17.810.016% mcap6.7% of flowCommon StockSEC:0001628280-21-017720:0
22,500 shares@ US$17.816.5% of flowCommon StockSEC:0001628280-21-017720
5,000 shares@ US$16.010.0032% mcap1.3% of flowCommon StockSEC:0001628280-21-016403:0
5,000 shares@ US$16.011.3% of flowCommon StockSEC:0001628280-21-016403
5,000 shares@ US$13.860.0028% mcap1.1% of flowCommon StockSEC:0001628280-21-014882:0
5,000 shares@ US$13.861.1% of flowCommon StockSEC:0001628280-21-014882
5,000 shares@ US$13.761.1% of flowCommon StockSEC:0001628280-21-012730
5,000 shares@ US$13.760.0027% mcap1.1% of flowCommon StockSEC:0001628280-21-012730:0
20,000 shares@ US$3.020.0024% mcap1.0% of flowCommon StockSEC:0001628280-21-010021:0
20,000 shares@ US$3.021.0% of flowCommon StockSEC:0001628280-21-010021
25 of 25 declarations
About Martin Michael Robert
Martin Michael Robert is an executive at Aurinia Pharmaceuticals Inc.
